Compare ASBP & DPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASBP | DPU |
|---|---|---|
| Founded | 2021 | N/A |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8M | 6.8M |
| IPO Year | 2021 | 2022 |
| Metric | ASBP | DPU |
|---|---|---|
| Price | $7.67 | $2.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 37.3K | 9.1K |
| Earning Date | 04-08-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.05 | $1.62 |
| 52 Week High | $8.17 | $2.60 |
| Indicator | ASBP | DPU |
|---|---|---|
| Relative Strength Index (RSI) | 58.00 | 59.06 |
| Support Level | $4.44 | $1.72 |
| Resistance Level | $8.11 | N/A |
| Average True Range (ATR) | 0.59 | 0.22 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 85.55 | 75.51 |
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.